Chronic Intranasal Treatment with an Anti-Aβ30-42 scFv Antibody Ameliorates Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease

Susann Cattepoel(University of Zurich), Roger M. Nitsch(University of Zurich)
PLoS ONE
April 5, 2011
10.1371/journal.pone.0018296
Cited by 71

Related Papers

Tau Filament Formation in Transgenic Mice Expressing P301L Tau
|Journal of Biological Chemistry|2001|515
Passive Immunization against β-Amyloid Peptide Protects Central Nervous System (CNS) Neurons from Increased Vulnerability Associated with an Alzheimer’s Disease-causing Mutation
|Journal of Biological Chemistry|2002|59